Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.
Michelle Marlborough
Advertisement
Chief product officer, AiCure, LLC
Articles by Michelle Marlborough
Advertisement
Latest Updated Articles
Why Machine Learning's Potential in Pharma Relies on Its TransparencyPublished: April 21st 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
4
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
5
